Bench to Bedside Speakers

Suchismita Acharya, PhD
CEO, AyuVis Research Inc
Assistant Professor, North Texas Eye Research Institute
Pharmacology & Neuroscience, UNT Health Science Center

Thomas W. Chalberg, PhD
Founder, Polymerase Capital
Founder, Exhaura Ltd.
Executive Chairman, iRenix

Louis C. Cullman, Esq.
Partner, K&L Gates, LLP

Alon Harris, MS, PhD, FARVO
Department of Ophthalmology, Icahn School of Medicine at Mount Sinai

Thurein Htoo, MS, MBS
Qlaris Bio, Inc.
Starlight Bio, Inc.

Darius Kharabi, JD, MBA
Chief Business Officer at Kala Pharmaceuticals

Saho Murakami, MD
Office of New Drug Ⅲ, Pharmaceuticals and Medical Devices Agency (PMDA)

Tieuvi Nguyen, PhD
Director, Division of Ophthalmic Devices, FDA

Susan Orr
CMO, Claris Biotherapeutics

Hema Ramkumar, MD
CEO, Oculogenex 

Stella Robertson, PhD, FARVO
Arrochar Consulting, LLC; Bios Partners, LP

Cynthia A. Toth, MD
Joseph AC Wadsworth Professor of Ophthalmology and Professor of Biomedical Engineering, Duke University
Chief Medical Officer, Theia Imaging LLC